本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ascendis Pharma A/S

174.96
-1.5300-0.87%
盤後174.960.00000.00%17:23 EDT
成交量:38.73萬
成交額:6,787.28萬
市值:105.95億
市盈率:-27.80
高:177.18
開:176.42
低:173.78
收:176.49
資料載入中...
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans